Neurodegeneration is among the most critical challenges that involve modern societies and
annually influences millions of patients worldwide. While the pathophysiology of Parkinson's …

Mitochondrial dysfunction is one of the crucial factors involved in PD's pathogenicity, which
emerges from a combination of genetic and environmental factors. These factors cause …

Parkinson's disease (PD) is a neurodegenerative disease still without any cure. Brain-
derived neurotrophic factor (BDNF) has shown therapeutic potential in PD, which is limited …

Parkinson's disease (PD) is known as a progressive neurodegenerative disorder associated
with the reduction of dopamine‐secreting neurons and the formation of Lewy bodies in the …

Parkinson's disease (PD) is known as one of the most common degenerative disorders
related to the damage of the central nervous system (CNS). This brain disorder is also …

Neurodegenerative disorders, such as Alzheimer's and Parkinson's disease, are
characterized by the progressive loss of neuronal cells, resulting in different clinical …

Rotenone (ROT) is an environmental neurotoxin which has been demonstrated to cause
characteristic loss of dopamine (DA) neurons in Parkinson's disease (PD). Icariin (ICA) is a …

Parkinson's disease, often known as PD, is a more common age-related neurological
disorder that affects a huge number of older adults worldwide. Parkinson's disease is …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease, and
oxidative stress and mitochondrial dysfunction play a major role in the pathogenesis of PD …

Abstract L-3, 4-dihydroxyphenylalanine (L-DOPA) was introduced about half a century ago
and is still the most effective medicine for the treatment of Parkinson's disease (PD) …